AC Immune SA Files March 2025 6-K with Press Release and 2024 Report
Ticker: ACIU · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, annual-report, press-release
TL;DR
AC Immune SA dropped its March 6-K, including a press release and 2024 annual report. Check it out.
AI Summary
AC Immune SA filed a Form 6-K on March 13, 2025, reporting its activities for March 2025. The filing includes a press release dated March 13, 2025, and its 2024 Annual Report. The company is headquartered at EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.
Why It Matters
This filing provides investors with updated information and the company's comprehensive 2024 performance report, crucial for assessing its current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial events or significant strategic changes.
Key Players & Entities
- AC Immune SA (company) — Registrant
- March 13, 2025 (date) — Press Release Date
- 2024 (date) — Annual Report Year
- Andrea Pfeifer (person) — Signatory
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025.
What exhibits are included with this Form 6-K?
The filing includes Exhibit 99.1, a Press Release dated March 13, 2025, and Exhibit 99.2, the 2024 Annual Report.
Who signed this report on behalf of AC Immune SA?
The report was signed by Andrea Pfeifer, pursuant to the requirements of the Securities Exchange Act of 1934.
What is AC Immune SA's principal executive office address?
The principal executive offices are located at EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.
Does AC Immune SA file annual reports under Form 20-F or 40-F?
AC Immune SA files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 by Andrea Pfeifer regarding AC Immune SA (ACIU).